Early Intervention for Patients with Substance Use Disorders

Overview

About this study

After the realization of the high utilization of healthcare resources (i.e. high readmission rates) by patients with Substance Use Disorders (SUD), a quality improvement pilot was launched at MCR to increase the referral rate to Licensed Alcohol and Drug Counselors (LADCs) by hospitalized patients with SUD. This was done by increasing their availability through a telemedicine inpatient consultation facilitated by increased collaboration between inpatient Social Workers/Case Managers, outpatient Mayo Clinic employed LADCs, and the primary Hospital Internal Medicine team. Phase I of this project was completed using retrospective chart review, and showed an increase in the referral rate from baseline data. The next goal is to perform Phase II of the study by performing telephone surveys to obtain more data on patient outcomes not available from chart review, such as relapse rates, readmisson rates (including admission to outside institutions), and chemical dependency treatment initiation and completion rates.

We seek to investigate the role and potential benefit of early intervention in patients admitted with substance use disorders. We hypothesize that early intervention in the inpatient setting, notably with use of telemedicine, may improve outcomes and treatment adherence. This study will investigate patient perception of the intervention, and explore post-intervention outcomes. Exploration of the potential value of early intervention of hospitalized patients has broad ranging application, as this population of patients are heavy consumers of hospital resources and are frequently re-admitted to the inpatient setting. Publication of this investigation designed to directly inform others and hopefully share any potential benefits from this intervention and have a broader impact on the management of patients with SUD at other institutions or healthcare facilities.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult, ≥ 18 years old.
  • Patients who received an LADC consultation associated with their hospital admission.
  • Deemed to have capacity.

Exclusion Criteria:

  • < 18 years old.
  • Consult placed but not completed.
  • Patient who have declined survey or study involvement.
  • Lack of capacity.
  • Non-English speaking.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Robert Kirchoff, M.D., M.S.

Closed for enrollment

Contact information:

Robert Kirchoff M.D., M.S.

(507) 255-8716

Kirchoff.Robert@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20525705

Mayo Clinic Footer